10X Genomics Inc
NASDAQ:TXG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
10X Genomics Inc
NASDAQ:TXG
|
US |
|
E
|
Equity Bancshares Inc
NYSE:EQBK
|
US |
Multiples-Based Value
The
Multiples-Based Value for
10X Genomics Inc (TXG)
under the Base Case is
21.41
USD.
Compared with the current market price of 24.8 USD, the stock appears
Overvalued by 14%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
TXG Competitors Multiples
10X Genomics Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
10X Genomics Inc
NASDAQ:TXG
|
3.2B USD | 4.8 | -70.3 | -40.5 | -25.7 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 353.9 | 4 190.9 | 1 200.8 | 2 312.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
198.4B USD | 4.5 | 29.6 | 20.4 | 27.4 | |
| US |
|
Danaher Corp
NYSE:DHR
|
140.4B USD | 5.7 | 38.8 | 19.7 | 28.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
317.9B CNY | 7 | 16.6 | 17.4 | 17.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.5B CHF | 5.5 | -129.5 | 17.5 | 27.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34B USD | 4.8 | 26.4 | 19.4 | 22.9 | |
| US |
|
Waters Corp
NYSE:WAT
|
32.5B USD | 10.3 | 50.5 | 32.6 | 41 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.7B USD | 1.8 | 22 | 12.1 | 18.2 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.3B USD | 6.8 | 31.4 | 23.2 | 25.8 |